首页> 外文期刊>Clinical & developmental immunology. >Analysis of Immune Responses in Mice Orally Immunized with Recombinant pMG36e-SP-TSOL18/Lactococcus lactis and pMG36e-TSOL18/Lactococcus lactis Vaccines of Taenia solium
【24h】

Analysis of Immune Responses in Mice Orally Immunized with Recombinant pMG36e-SP-TSOL18/Lactococcus lactis and pMG36e-TSOL18/Lactococcus lactis Vaccines of Taenia solium

机译:用重组PMG36E-SP-TSOL18 /乳球菌乳酸乳乳乳乳乳乳乳杆菌和PMG36E-TSOL18 /乳球菌乳酸乳乳乳乳乳乳乳乳乳球菌免疫应答分析

获取原文
       

摘要

Cysticercosis is a cosmopolitan zoonotic parasitic disease infected by larval of Taenia solium ( T. solium ). Several drugs for the treatment of cysticercosis, such as praziquantel, albendazole, and mebendazole, have certain toxicity and side effects. Considering that there is no vaccine available, we studied a new vaccine for cysticercosis in this study. The complete TSOL18 gene and the optimized SP-TSOL18 gene fragments were obtained using PCR-based accurate synthesis method. The secretory and intracellular recombinant pMG36e-SP-TSOL18/ Lactococcus lactis ( L. lactis ) and pMG36e-TSOL18/ L. lactis vaccines of T. solium were prepared. Immune responses in mice orally immunized with these two recombinant L. lactis vaccines were analyzed by the determination of specific antibodies (IgG, IgG1, IgG2a, and sIgA) in serum, spleen lymphocyte proliferation, and cytokines (IL-2, IFN- γ , IL-4, and IL-10) in spleen lymphocyte culture supernatant. Our results showed that, after the first immunization, in these two recombinant L. lactis vaccine groups, the levels of serum specific IgG, IgG2a, and IgG1 increased on 14–56?d and reached the highest level on days 42, 42, and 28, respectively. The level of specific sIgA of intestinal mucosa also increased on 14–56?d and reached the highest level on day 42. The level of spleen lymphocyte proliferation increased on 14–56?d and reached the highest level on day 42. The levels of IL-2, IFN- γ , IL-4, and IL-10 in spleen lymphocyte culture supernatant increased on 14–56?d and reached the highest level on days 42, 42, 28, and 28, respectively. These results indicated that the recombinant pMG36e-SP-TSOL18/ L. lactis and pMG36e-TSOL18/ L. lactis vaccines can induce specific cellular, humoral, and mucosal immune responses in mice with oral vaccination. More importantly, the recombinant pMG36e-SP-TSOL18/ L. lactis vaccine has a better immune effect. In summary, these results demonstrated the possibility of using L. lactis strain as a vector to deliver protective antigens of T. solium .
机译:囊尾蚴病是一种由Taenia Solium(T.Solium)的幼虫感染的大都会动物寄生疾病。几种用于治疗膀胱霉病的药物,如吡喹酮,阿美唑和兆唑,具有一定的毒性和副作用。考虑到没有可用疫苗,我们研究了这项研究中的新疫苗进行囊尾蚴病。使用PCR基精确合成方法获得完整的TSOL18基因和优化的SP-TSOL18基因片段。制备分泌和细胞内重组PMG36E-SP-TSOL18 /乳球菌乳酸乳乳乳乳乳乳乳乳乳乳乳乳乳乳乳乳杆菌剂。通过测定血清,脾脏淋巴细胞增殖和细胞因子(IL-2,IFN-γ,Cytokines中的特异性抗体(IgG,IgG1,IgG2A和SIGA)来分析用这两个重组L.乳酸疫苗疫苗的小鼠的免疫反应进行分析脾脏淋巴细胞培养上清液中的IL-4和IL-10)。我们的结果表明,在第一次免疫之后,在这两种重组L.乳酸疫苗基团中,血清特异性IgG,IgG2a和IgG1的水平在14-56℃上增加,并在第42,42天达到最高水平分别为28。肠粘膜特异性SIGA的水平也在14-56?D上增加,并在第42天达到最高水平。脾脏淋巴细胞增殖水平在14-56?D上增加,并在第42天达到最高水平。脾脏淋巴细胞培养上清液中IL-2,IFN-γ,IL-4和IL-10分别在14-56℃上增加,分别在第42,42,28和28天达到最高水平。这些结果表明,重组PMG36E-SP-TSOL18 / L.乳酸乳裂和PMG36E-TSOL18 / L.乳酸疫苗可诱导具有口腔疫苗的小鼠中的特定细胞,体液和粘膜免疫应答。更重要的是,重组PMG36E-SP-TSOL18 / L.乳酸疫苗具有更好的免疫效果。总之,这些结果证明了使用L.乳酸菌菌株作为载体的可能性,以递送T.棒的保护性抗原。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号